Tempus AI vs Eleos Health
A detailed comparison to help you choose between Tempus AI and Eleos Health.
⚖️
How to choose
Neither tool has user reviews on ToolSpotter yet, so we don't pick a winner. Compare them on what they're built for: Tempus AI — Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access.; Eleos Health — Community-based behavioral health and SUD organizations with 20+ clinicians that need documentation support and pre-submission compliance review inside an existing web-based EHR..
Tempus AI AI for precision medicine and clinical genomics | Eleos Health AI-powered therapy insights through voice analysis | |
|---|---|---|
| Rating | 4.1 (1 review) | 4.1 (1 review) |
| Pricing Model | paid | paid |
| Starting Price | From $1000/mo | From $99/mo |
| Best For | Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access. | Community-based behavioral health and SUD organizations with 20+ clinicians that need documentation support and pre-submission compliance review inside an existing web-based EHR. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | ssoteam features | gdpr compliantapi accessteam features |
| Visit Tempus AI → | Visit Eleos Health → |
Tempus AI
Pros
- + FY2025 revenue of $1.3B with 126% net revenue retention and >$1.1B remaining contract value — verifiable public-company financials, not marketing claims
- + Complete assay portfolio in one relationship: xT/xR comprehensive profiling, xF+ liquid biopsy, MRD monitoring, Ambry hereditary testing and OneOme pharmacogenomics (national launch July 2026)
- + Tempus One answered voice queries against the patient's own clinical and molecular profile in my testing, with report citations instead of generic text
- + Paige Predict extends the platform into digital pathology — 123 biomarkers predicted from standard H&E slides across 16 cancer types (vendor-published validation)
- + Trial matching is built into the report workflow, which is the practical bottleneck for oncology coordinators
Cons
- - No self-serve access, no trial, and no published pricing of any kind — the $1,000 entry figure floating around listings could not be verified
- - Oncology-first scope; primary care and non-oncology specialties have little reason to engage
- - Still net-loss-making (-$245.0M in 2025), and the portfolio is stitched from four recent acquisitions (Ambry, Paige, OneOme, Deep 6)
- - Model-performance and data-library claims are company-published; independent third-party validation is thinner than the press-release volume suggests
- - Enterprise sales motion means long procurement cycles for health systems
Eleos Health
Pros
- + EHR-agnostic browser-extension deployment means no API or HL7 integration project — in my walkthrough it sat on top of a web-based EHR with no custom build.
- + Compliance engine reviews 100% of notes against seven named checks (Uniqueness through Golden Thread) instead of the 5-10% sample rate manual QA teams manage.
- + Speech handling covers 150+ languages including mixed-language speech like Spanglish, which matches the bilingual caseloads common in community mental health.
- + 2026 agent additions (Eligibility Intelligence, Coding Agent) target revenue leakage upstream; early customers report 25% fewer Medicaid clients misclassified as uninsured.
- + Deep compliance posture: SOC 2, HITRUST, ISO 27001/27799/42001 certifications, HIPAA and FERPA compliance.
Cons
- - No self-serve signup, public pricing or free trial; market rates I found run $129/user/month (Documentation) and $119/user/month (Compliance) with $50k annual minimums (Indiana Council purchasing doc, May 2025).
- - Implementation fees in the $10,000-$30,000+ range make the product unreachable for small practices and solo clinicians.
- - Headline outcome stats (70% less admin time, 20% less turnover) are vendor-reported with no independent study I could find.
- - Vendor copy contradicts itself: the compliance page heads a '7-Point Compliance Analysis' but the body claims a 'six-point' review.
- - Group therapy documentation only shipped in September 2025, so that mode is much newer than the individual-session flow.
Frequently Asked Questions
Which is better, Tempus AI or Eleos Health?▼
It depends on your specific needs — neither tool has user reviews on ToolSpotter yet, so we don't rank one above the other. Tempus AI is best for: Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access.. Eleos Health is best for: Community-based behavioral health and SUD organizations with 20+ clinicians that need documentation support and pre-submission compliance review inside an existing web-based EHR..
What is the difference between Tempus AI and Eleos Health?▼
Tempus AI: Tempus AI runs clinical and genomic sequencing and builds the diagnostics and data products used in precision oncology and other specialties. Eleos Health: AI platform that analyzes therapy sessions through voice to provide real-time insights and improve mental health outcomes.
Is Tempus AI or Eleos Health more affordable?▼
Tempus AI starts at €1000/mo, Eleos Health starts at €99/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.